Browse by Category


Makena Found Not Effective at Reducing Premature Birth

In a surprise result, a study of a drug designed to lower the risk of premature birth was shown to be no better than a placebo. Update, October 30, 2019 An FDA Advisory Committee met to review Makena (17-α hydroxyprogesterone injection or 17-OHPC) in light of the new post-approval study…